Showing 221 - 240 results of 497 for search '"Фармакоэкономика"', query time: 0.06s Refine Results
  1. 221
    CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT

    CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT by I. I. Shteynberg, S. K. Zyryanov, Yu. B. Belousov

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 222
    Strengthening medical rehabilitation services in health system: a situation analysis

    Strengthening medical rehabilitation services in health system: a situation analysis by D. V. Blinov, A. G. Solopova, L. N. Sandzhieva, E. E. Achkasov, D. I. Korabelnikov, D. M. Ampilogova, S. M. Khlopkova

    Published 2022-07-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 223
    The prospects for the use of vitamin B12 derivatives in pharmacology

    The prospects for the use of vitamin B12 derivatives in pharmacology by I. Yu. Torshin, O. A. Gromova, L. A. Maiorova

    Published 2023-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 224
    Features of intellectual property protection mechanisms on the example of orphan drugs circulation

    Features of intellectual property protection mechanisms on the example of orphan drugs circulation by D. S. Yurochkin, К. V. Nasonova, Z. М. Golant, I. А. Narkevich, V. P. Trukhin

    Published 2022-01-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 225
    PHARMACOECONOMIC EVALUATION OF INFLUENZA AND PNEUMOCOCCAL VACCINATION IN EMPLOYEES OF THE JOINT STOCK COMPANY "RUSSIAN RAILWAYS" (JSCO "RZD") ON INVESTMENT FOR THE EMPLOYER

    PHARMACOECONOMIC EVALUATION OF INFLUENZA AND PNEUMOCOCCAL VACCINATION IN EMPLOYEES OF THE JOINT STOCK COMPANY "RUSSIAN RAILWAYS" (JSCO "RZD") ON INVESTMENT FOR THE EMPLOYER by D. A. Zhukov

    Published 2016-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 226
    What is the role of antineoplastic drug safety in reimbursement decision making?

    What is the role of antineoplastic drug safety in reimbursement decision making? by A. S. Kolbin, A. A. Kurylev

    Published 2018-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 227
    Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support

    Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support by E. V. Eliseeva, E. S. Maneeva, R. K. Goncharova, A. V. Kropotov

    Published 2019-10-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 228
    Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia

    Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia by V. G. Deriushkin, A. P. Ternavskii, S. V. Gatsura

    Published 2021-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 229
    Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations

    Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered... by M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov

    Published 2018-08-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 230
    Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines

    Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines by I. K. Petrukhina, R. I. Yagudina, N. V. Veyner, T. K. Ryazanova, E. P. Gladunova, V. A. Kurkin, P. R. Blinkova, E. N. Zaitseva

    Published 2021-10-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 231
    METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES

    METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES by R. I. Yagudina, I. V. Sorokovikov

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 232
    Clinical and economic analysis of using the thrombodynamics test in patients undergoing treatment with assisted reproductive technologies in the Russian Federation

    Clinical and economic analysis of using the thrombodynamics test in patients undergoing treatment with assisted reproductive technologies in the Russian Federation by D. G. Shchurov, V. S. Dombrovskiy

    Published 2021-07-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 233
    Modern biomarkers of acute kidney injury

    Modern biomarkers of acute kidney injury by D. I. Korabelnikov, M. O. Magomedaliev

    Published 2023-04-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 234
    PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS

    PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS by A. Yu. Kulikov, V. G. Serpik

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 235
    Pharmacoeconomic aspects of COVID-19 treatment

    Pharmacoeconomic aspects of COVID-19 treatment by I. V. Rogova, E. A. Zhidkova, I. A. Popova, A. V. Zaborovskiy, K. G. Gurevich

    Published 2021-10-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 236
    THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT

    THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT by D. V. Lukyantseva, L. S. Mel’nikova, A. P. Tatarinov

    Published 2018-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 237
    PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS

    PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMP... by A. S. Kolbin, I. A. Vilum, М. A. Proskurin, Yu. E. Balykina

    Published 2017-05-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 238
    COST-UTILITY ANALYSIS PATIENTS WITH LOW BACK PAIN AFTER TREATMENT INTRAOSSEOUS BLOCKADES

    COST-UTILITY ANALYSIS PATIENTS WITH LOW BACK PAIN AFTER TREATMENT INTRAOSSEOUS BLOCKADES by M. V. Yakovlev, A. U. Kulikov, E. L. Sokov, I. E. Kornilova

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 239
    PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY)

    PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY) by D. Kh. Kalimullina, A. S. Yurkina, T. I. Ushakova, D. V. Blinov

    Published 2017-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 240
    Chemoproteomic analysis of the pharmacological properties of vitamin В12 derivatives

    Chemoproteomic analysis of the pharmacological properties of vitamin В12 derivatives by I. Yu. Torshin, O. A. Gromova, I. A. Dereven’kov, L. A. Maiorova

    Published 2024-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: